PFGIA
AGIO icon

Patriot Financial Group Insurance Agency’s Agios Pharmaceuticals AGIO Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-350
Closed -$12K – 2031
2021
Q4 		$12K Buy
350
+200
+133% +$8.05K ﹤0.01% 1409
2021
Q3 		$7K Buy
+150
New +$7.25K ﹤0.01% 1583

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Patriot Financial Group Insurance Agency's AGIO Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of Agios Pharmaceuticals (AGIO) in Q1 2022, closing a stake of 350 shares — an estimated $12K sold.

Patriot Financial Group Insurance Agency first reported a position in AGIO in Q3 2021 and held it in 2 quarters. The position peaked at $12K in Q4 2021. 161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Agios Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 350 Agios Pharmaceuticals shares in Q1 2022, an estimated $12K.
  • Patriot Financial Group Insurance Agency first reported a position in Agios Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Patriot Financial Group Insurance Agency's Agios Pharmaceuticals position peaked at $12K in Q4 2021.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.